Contact Supplier

Contact Supplier

To get in touch with MEGGLE Excipients, simply fill out the form below.

    Subscribe to Supplier

    Subscribe to Supplier


    MEGGLE to highlight InhaLac® dry powder inhalation qualities at Excipient World 2024

    news-releasesMEGGLE Excipients
    May 7th 2024

    Wasserburg, Germany: – Pharmaceutical lactose specialist MEGGLE will be a prominent presence at the 2024 Excipient World meeting in Florida, with a presentation of the strengths of its lactose-based InhaLac® range for dry powder inhaler (DPI) applications.

    MEGGLE will be represented at the meeting by its American distributor Barentz US, who will exhibit from Booth 103 in the Exhibition Zone at the  Gaylord Palms Resort & Convention Center in Kissimmee, near Orlando. MEGGLE USA Director, Lew Jackson, will join the Barentz stand team.

    Pulmonary Excipient applications 

    Barentz will also contribute to the conference agenda, with their Technical & Development Manager Mary Tanenbaum and Global Technical and Marketing Director Paul Woodcock giving a Day Two presentation on ‘The Evolution of The Role of Excipients In Pulmonary Drug Delivery’ (May 14, 0945-1005 hrs., Exhibit Hall Stage 1).

    The presentation will review the developments in pulmonary drug delivery in recent years and show what challenges remain and where further research is needed. The talk will particularly focus on the qualities required of excipients such as MEGGLE’s InhaLac® to optimize drug delivery while making them environmentally and patient friendly.

    Lew Jackson commented: “We are very pleased to be partnering with Barentz for this event. I have no doubt that by the end of the meeting, they will have shown the delegates at Excipient World that MEGGLE has it, both in terms of the right lactose product for DPI, but also for every other dosage form as well, with displays on our other brands, such as FlowLac®, GranuLac®, and DuraLac®.”

    About MEGGLE Wasserburg

    Bavarian-based company MEGGLE is one of the world’s experts in co-processing and powder technology. From its roots as a dairy operation in the late 1880’s, MEGGLE has become one of the world’s leading manufacturers of pharmaceutical grade lactose, supplying the pharmaceutical industry with a broad-based and unique lactose product portfolio.

    MEGGLE’s Business Unit Excipients has harnessed outstanding product quality and intelligent innovation to become a global leader in the manufacture of lactose-based excipients, focusing on products for direct tableting and dry powder inhalation.

    A multidisciplinary team of committed and highly qualified people allows MEGGLE clients to benefit from pioneering experience and innovation in industrial milk and whey processing. The company constantly strives to develop high-technological, functional products for solid dosage forms and DPI applications, where they can deliver maximum performance.

    The company has introduced several revolutionary products, notably Tablettose®, the world’s first agglomerated pharmaceutical lactose grade for direct tableting, Cellactose® 80, a pioneering co-processed excipient based on powdered cellulose and lactose for outstanding compression and flow properties and RetaLac®, the first direct compressible co-processed excipient using Hypromellose and lactose for sustained release formulations.

    To learn more, visit:

    About Excipient World  2024

    The Excipient World forum is the annual meeting of IPEC-Americas, a member of the Brussels-based International Pharmaceutical Excipients Council Federation, whose mission is to develop, implement, and promote voluntary, harmonized guidance and other programs designed to enhance the quality of pharmaceutical excipients.

    The Excipient World conference attracts pharmaceutical professionals from America and around the world for a unique forum focused on excipients that presents cutting-edge scientific developments, formulation and technology advancements, quality production and the safe use of excipients, as well as latest regulatory mandates, bringing  buyers and suppliers together to explore new product innovations and potential collaborations.

    Excipient World 2024 is a three-day event opening May 13 at the Gaylord Palms Resort & Convention Center, at Kissimmee, near Orlando, Florida. Two days of conference sessions will be followed by a further day of workshops.

    The event is organized by IPEC Federation with further information at:


    Click on Highest quality for dry powder inhalation for further information.
    Click on MEGGLE DPI technologies to view video.


    Experts in Excipients - The whole world of Lactose

    MEGGLE to highlight InhaLac® dry powder inhalation qualities at Excipient World 2024

    Excipient World forum is organized by IPEC-Americas.

    MEGGLE to highlight InhaLac® dry powder inhalation qualities at Excipient World 2024

    MEGGLE InhaLac® sieved, milled and micronized lactose-based excipients support a wide range of Dry Powder Inhalation (DPI) applications.

    Contact MEGGLE Excipients

    Simply fill out the form below to contact MEGGLE Excipients now.

    Send MEGGLE Excipients a Message